Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients

NCT07690943 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
COVID-19 (SARS-CoV-2 Infection)

Interventions

BIOLOGICAL: LB-DTK-COV19

Sponsor

LucasBio